Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124606273 | 12460627 | 3 | F | 201512 | 20160830 | 20160613 | 20160906 | EXP | US-PFIZER INC-2016294648 | PFIZER | 77.00 | YR | M | Y | 77.00000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124606273 | 12460627 | 1 | PS | VFEND | VORICONAZOLE | 1 | 200 MG, 2X/DAY | Y | F10201930 | 21266 | 200 | MG | BID | ||||||
| 124606273 | 12460627 | 2 | SS | VFEND | VORICONAZOLE | 1 | Y | 21266 | |||||||||||
| 124606273 | 12460627 | 3 | C | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | 150 MG, 2X/DAY, ONE IN MORNING AND ONE AT NIGHT | 0 | 150 | MG | BID | ||||||||
| 124606273 | 12460627 | 4 | C | PROPAFENONE. | PROPAFENONE | 1 | 150 MG, 2X/DAY, ONE IN MORNING AND ONE AT NIGHT | 0 | 150 | MG | BID | ||||||||
| 124606273 | 12460627 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 2X/DAY, TWO IN MORNING AND TWO AT NIGHT | 0 | 300 | MG | BID | ||||||||
| 124606273 | 12460627 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 124606273 | 12460627 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 124606273 | 12460627 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 124606273 | 12460627 | 9 | C | DILTIAZEM. | DILTIAZEM | 1 | 180 MG, 1X/DAY | 0 | 180 | MG | QD | ||||||||
| 124606273 | 12460627 | 10 | C | LEVALBUTEROL /01419301/ | 2 | UNK, 4X/DAY | 0 | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124606273 | 12460627 | 1 | Aspergillus infection |
| 124606273 | 12460627 | 2 | Lung infection |
| 124606273 | 12460627 | 3 | Atrial fibrillation |
| 124606273 | 12460627 | 4 | Atrial fibrillation |
| 124606273 | 12460627 | 5 | Herpes zoster |
| 124606273 | 12460627 | 6 | Burning sensation |
| 124606273 | 12460627 | 7 | Paraesthesia |
| 124606273 | 12460627 | 8 | Dyskinesia |
| 124606273 | 12460627 | 9 | Atrial fibrillation |
| 124606273 | 12460627 | 10 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124606273 | 12460627 | OT |
| 124606273 | 12460627 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124606273 | 12460627 | Cardiac failure congestive | |
| 124606273 | 12460627 | Chronic obstructive pulmonary disease | |
| 124606273 | 12460627 | Pneumonia | |
| 124606273 | 12460627 | Pneumonia bacterial |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124606273 | 12460627 | 1 | 201510 | 0 | ||
| 124606273 | 12460627 | 3 | 2014 | 0 | ||
| 124606273 | 12460627 | 4 | 2015 | 2016 | 0 | |
| 124606273 | 12460627 | 5 | 2015 | 0 | ||
| 124606273 | 12460627 | 9 | 2014 | 0 | ||
| 124606273 | 12460627 | 10 | 2016 | 0 |